Important Notice
*In response to the August 2021 FDA Class 2 Device Recall of the Trilogy EV300, the SNS recovered and/or replaced all Philips Trilogy EV300 ventilator models deployed to U.S. health jurisdictions for COVID-19. SNS is coordinating closely with federal and commercial partners to resolve the recall issue.
The Trilogy EV300 ventilator delivers enhanced performance in noninvasive (NIV) and invasive (IV) ventilation, so patients can be treated with a single device throughout their hospital stay, regardless of changing conditions.
Resources
Contact Us
For further questions or information about the Strategic National Stockpile, please email us at sns.ops@cdc.gov
